hENT1 as a Predictive Biomarker in PDAC—Letter

Lenka N. C. Boyd; Mahsoem Ali; Jisce R. Puik; Laura L. Meijer; Tessa Y. S. le Large; Hanneke W. M. van Laarhoven; Elisa Giovannetti; Geert Kazemier

doi:https://doi.org/10.1158/1078-0432.CCR-22-3827

hENT1 as a Predictive Biomarker in PDAC—Letter

Lenka N. C. Boyd, Mahsoem Ali, Jisce R. Puik, Laura L. Meijer, Tessa Y. S. le Large, Hanneke W. M. van Laarhoven, Elisa Giovannetti, Geert Kazemier

Research output: Contribution to journal › Comment/Letter to the editor › Academic

Original language	English
Pages (from-to)	2944
Number of pages	1
Journal	Clinical Cancer Research
Volume	29
Issue number	15
DOIs	https://doi.org/10.1158/1078-0432.CCR-22-3827
Publication status	Published - 1 Aug 2023

Access to Document

https://doi.org/10.1158/1078-0432.CCR-22-3827

Cite this

@article{7d5a4a25746e4e2aab2ab7d7f7161d27,

title = "hENT1 as a Predictive Biomarker in PDAC—Letter",

author = "Boyd, {Lenka N. C.} and Mahsoem Ali and Puik, {Jisce R.} and Meijer, {Laura L.} and {le Large}, {Tessa Y. S.} and {van Laarhoven}, {Hanneke W. M.} and Elisa Giovannetti and Geert Kazemier",

note = "Funding Information: This article was funded by the Dutch Cancer Society (to G. Kazemier and E. Giovannetti), Bennink Foundation (the Netherlands; to G. Kazemier, L.N.C. Boyd, M. Ali, J.R. Puik, and E. Giovannetti) and Italian Association for Cancer Research (Italy; to E. Giovannetti).",

year = "2023",

month = aug,

day = "1",

doi = "https://doi.org/10.1158/1078-0432.CCR-22-3827",

language = "English",

volume = "29",

pages = "2944",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "15",

}

TY - JOUR

T1 - hENT1 as a Predictive Biomarker in PDAC—Letter

AU - Boyd, Lenka N. C.

AU - Ali, Mahsoem

AU - Puik, Jisce R.

AU - Meijer, Laura L.

AU - le Large, Tessa Y. S.

AU - van Laarhoven, Hanneke W. M.

AU - Giovannetti, Elisa

AU - Kazemier, Geert

N1 - Funding Information: This article was funded by the Dutch Cancer Society (to G. Kazemier and E. Giovannetti), Bennink Foundation (the Netherlands; to G. Kazemier, L.N.C. Boyd, M. Ali, J.R. Puik, and E. Giovannetti) and Italian Association for Cancer Research (Italy; to E. Giovannetti).

PY - 2023/8/1

Y1 - 2023/8/1

UR - http://www.scopus.com/inward/record.url?scp=85168573370&partnerID=8YFLogxK

U2 - https://doi.org/10.1158/1078-0432.CCR-22-3827

DO - https://doi.org/10.1158/1078-0432.CCR-22-3827

M3 - Comment/Letter to the editor

C2 - 37525961

SN - 1078-0432

VL - 29

SP - 2944

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 15

ER -

hENT1 as a Predictive Biomarker in PDAC—Letter

Access to Document

Other files and links

Cite this